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ABSTRACT
Objective: The aim of this study was to assess epithelial expression of E-cadherin and c-Met in normal lip, in actinic cheilitis and lip squamous 
cell carcinoma. Study Design: %LRSVLHV RI QRUPDO OLS YHUPLOOLRQ 1/ Q  DFWLQLF FKHLOLWLV $& Q  DQG OLS 6&& Q ZHUH SURFHVVHG
for E-cadherin and c-Met immunodetection. Epithelial and tumor cell expression was scored for each sample considering staining intensity and 
percentage. Results: E-cadherin expression was significantly reduced in AC and lip SCC as compared to normal lip (P<0.05), with a significant 
UHGXFWLRQLQOLS6&&DVFRPSDUHGWR$&3 ([SUHVVLRQRIF0HWZDVVLJQLILFDQWO\KLJKHULQ$&DQGOLS6&&DVFRPSDUHGWR1/3
with a significant increase in lip SCC as compared to AC (P<0.0001). Conclusion: The results showed that epithelial E-cadherin expression is 
reduced and c-Met expression is increased as lip carcinogenesis progresses, suggesting that these proteins may be useful markers of malignant 
transformation.
Rev. Clin. Periodoncia Implantol. Rehabil. Oral Vol. 4(3); 122-125, 2011.
Key words: E-cadherin, c-Met, lip carcinogenesis, UV light, actinic cheilitis, lip squamous cell carcinoma.
INTRODUCTION
 Chronic exposure of the lip vermillion to sunlight and/or artificial 
ultraviolet irradiation (UV) causes actinic cheilitis (AC), a pre-malignant 
lesion with the potential to develop into invasive lip squamous cell 
carcinoma (SCC), the most common form of oral cancer(1).
 E-cadherin is a calcium-dependent membranous glycoprotein 
that plays important roles in the maintenance of cell-cell adhesion, 
preservation of epithelial tissue polarity, and structural integrity(2,3). The 
inactivation of the E-cadherin cell adhesion system by both genetic 
and epigenetic mechanisms plays a significant role during multistage 
human carcinogenesis(3,4). Several studies demonstrate that reduction 
of E-cadherin expression occurs in oral dysplasia, with such reduction 
being proportional to the degree of dysplasia(5-7). E-cadherin expression 
is frequently down-regulated in a wide variety of human malignancies, 
including skin cancer(8), oral squamous carcinoma(4,7,9-11), lip SCC(12), 
gastric cancer(13,14), breast cancer(15), lung cancer(16), and prostate 
cancer(17). Reduced E-cadherin expression has been shown to be an 
indicator of unfavorable prognosis in oral squamous cell carcinoma and 
in other malignancies(9,10,18).
 Brouxhon et al.(6) demonstrated that during UV-induced skin 
carcinogenesis in SKH-1 mice, SCC progression produces a significant 
and progressive down-regulation of E-cadherin protein expression in 
epidermal keratinocytes as lesions progress from in situ carcinomas to 
large invasive SCCs.
 The proto-oncogene, c-Met, is a transmembrane tyrosine kinase 
receptor that mediates the oncogenic activities of the hepatocyte growth 
factor (HGF). Overexpression of c-Met and/or its ligands has been shown 
to contribute to progression and dissemination of several malignancies, 
such as gallbladder(19), gastric(20,21), bladder(22), breast(15), and head and 
neck cancer(7,18,23,24). The overexpression of c-Met frequently has been 
correlated with poor prognosis in various cancers(20,22).
 Several studies have found an inverse correlation between 
the expression of HGF/c-Met and membranous E-cadherin expression 
in human tumors(7,15,18,22). A limited number of studies have investigated 
E-cadherin expression in lip SCC(12). However, E-cadherin expression in 
AC has not been determined. In addition, the expression of E-cadherin 
and c-Met has not yet been studied in normal and photodamaged lips. 
Thus, the purpose of this study was to assess epithelial expression of 
E-cadherin and c-Met in normal lip, actinic cheilitis (premalignant lesion), 
and lip SCC samples.
MATERIALS AND METHODS
Biopsies
 Biopsies of lower lip vermillion from 37 non-smoking patients 
ZLWK $&  ZRPHQ DQG  PHQ DJH  \HDUV PHDQ 
years) were obtained from the Archives of the Oral Pathology Laboratory, 
School of Dentistry, University of Concepción; and biopsies of 22 lip SCC 
Q  ZHOOGLIIHUHQWLDWHG Q  PRGHUDWHO\GLIIHUHQWLDWHG Q  SRRUO\
GLIIHUHQWLDWHGZRPHQDQGPHQDJH\HDUVPHDQ
years) were obtained from the Archives of the Department of Pathology, 
School of Medicine, University of Concepción. Eighteen normal lip 
vermillion biopsies (12 women and 6 men, age 22-63 years, mean 
\HDUVZHUHXVHGDVFRQWUROV,QIRUPHGFRQVHQWZDVREWDLQHG
from all subjects. This study was approved by the Ethics Committee of the 
University of Concepción.
 All specimens were fixed in 10% buffered formalin, pH 7.4, 
DQGSDUDIILQHPEHGGHGZLWKLQKRXUV6HULDOVHFWLRQVȝPWKLFNZHUH
obtained from the tissue blocks and processed for histopathologic and 
immunohistochemical analyses.
Immunohistochemical Staining
 Tissue sections were deparaffinized in xylene and rehydrated 
in graded alcohol. Endogenous peroxidase activity was blocked by 
incubation in methanol with 3% hydrogen peroxide for 10 minutes. For 
antigen retrieval, tissue sections were steamed in EDTA buffer 0.001M 
(pH 8.0) at 96ºC for 30 minutes. After rinsing in phosphate-buffered saline 
(PBS), slides were incubated overnight with the monoclonal antibody 
Mouse E-Cadherin Ab-4 (Clone: NCH-38, dilution 1:100, NeoMarkers 
Laboratories, Fremont, CA, USA) and anti-c-Met monoclonal antibody 
(Clone: 3D4, dilution 1:100, Invitrogen, ZYMED Laboratories, Carlsbad, 
CA, USA). The primary antibody was diluted in Antibody Diluent (ZYMED, 
Carlsbad, CA, USA). This was followed by incubation with the UltraVision 
ONE HRP Polymer (LAB VISION, Fremont, CA, USA) for 30 minutes. 
Sections were then washed in PBS and the reaction was developed with 
DAB (3.3 diaminobenzidine Mouse/Rabbit Plydetector PDBSBA02A7, Bio 
SB) for 5 minutes at room temperature. Slides were counterstained with 
Harris hematoxylin. Positive controls were normal skin for E-cadherin, and 
a papillary thyroid carcinoma for c-Met. The negative controls consisted of 
replacing the first antibody with buffer and omitting the primary antibody.
 Epithelial staining scores for E-cadherin and c-Met were 
'HSDUWPHQWVRI2UDO3DWKRORJ\6FKRRORI'HQWLVWU\&ROOHJHRI0HGLFLQH8QLYHUVLW\RI&RQFHSFLyQ&KLOH
'HSDUWPHQWVRI3DWKRORJ\6FKRRORI'HQWLVWU\&ROOHJHRI0HGLFLQH8QLYHUVLW\RI&RQFHSFLyQ&KLOH
'HSDUWPHQWVRI3XEOLF+HDOWK6FKRRORI'HQWLVWU\&ROOHJHRI0HGLFLQH8QLYHUVLW\RI&RQFHSFLyQ&KLOH
'HSDUWPHQWVRI2UDO6XUJHU\6FKRRORI'HQWLVWU\&ROOHJHRI0HGLFLQH8QLYHUVLW\RI&RQFHSFLyQ&KLOH
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obtained for each sample by two calibrated observers, based on the 
combination of staining intensity and extension in each tissue section 
as previously described(25). For NL and AC samples, staining extension 
was evaluated at the basal, parabasal, and suprabasal epithelial layers 
of each sample. For lip SCC samples, the markers were evaluated in 
the tumor cells and in the stroma and defined as the percentage of 
positive cells/field (x40). Staining intensity for each marker was recorded 
as undetectable (0), weak (1), medium (2), or strong (3). Results were 
H[SUHVVHGDVWKHPHDQ6'
Statistical Analysis
 Data were analyzed with statistical software (SPSS, version 
16.0; SPSS, Inc, Chicago, Ill, USA). Differences between groups were 
examined using the Mann-Whitney test; differences were considered 
statistically significant when P<0.05.
RESULTS
 Figure 1 shows representative microphotographs of serial 
sections from normal lip, AC, and lip SCC biopsies immunostained for 
E-cadherin and c-Met. Strong membranous E-cadherin staining was 
found in nearly all the epithelial layers of normal lip, excluding the most 
superficial cells (Figure 1A). For AC specimens, moderate and weak 
membranous and non-membranous E-cadherin staining was found in 
basal, parabasal, and middle spinous cells but not in the superficial layers 
(Figure 1B). For lip SCC samples, the E-cadherin staining was weaker 
or lost (Figure 1C). Table 1 shows the cellular localization of E-cadherin 
expression in NL, AC, and lip SCC samples. E-cadherin expression 
was significantly reduced in AC and lip SCC as compared to normal lip 
(P<0.05, Mann-Whitney test), with a significant reduction in lip SCC as 
FRPSDUHGWR$&3 )LJXUH$
 Immunohistochemistry showed that c-Met expression in NL 
was negative or occasionally weak at the basal and parabasal epithelial 
layers (Figure 1D). Weak positive c-Met staining was observed at basal, 
parabasal, and suprabasal epithelial layers of AC samples (Figure 1E).
 In lip SCC samples c-Met was expressed at the membrane 
and cytoplasm of tumor cells (Figure 1F). Table 2 presents the cellular 
localization of c-Met expression in NL, AC, and lip SCC samples. 
Expression of c-Met was significantly higher in AC and lip SCC as 
compared to NL (P<0.05, Mann-Whitney test), with a significant increase 
in lip SCC as compared to AC (P<0.0001) (Figure 2B). In addition, c-Met 
expression was found in stromal cells from AC (2.3%) and lip SCC lesions 
(50.3%) (not shown). 
Figure 1. ,PPXQRKLVWRFKHPLFDOGHWHFWLRQRI(FDGKHULQDQGF0HWLQQRUPDOOLS(NL)DFWLQLF
FKHLOLWV(AC)DQGOLS6&&(A-C)5HSUHVHQWDWLYHPLFURSKRWRJUDSKVRIHSLWKHOLDO(&DGKHULQ(E-Cad) 
H[SUHVVLRQLQ1/(A)$&(B)DQGOLS6&&(C)VHFWLRQV(D-F) 5HSUHVHQWDWLYHPLFURSKRWRJUDSKVRI
HSLWKHOLDOF0HWH[SUHVVLRQLQ1/(D)$&(E)DQGOLS6&&(F)VHFWLRQV%DUUHSUHVHQWVȝP
Figure 2.([SUHVVLRQVFRUHIRU(FDGKHULQDQGF0(7LQQRUPDOOLS(NL)DFWLQLFFKHLOLWLV(AC)DQGOLS
6&&$FRPELQHGH[SUHVVLRQVFRUHRIVWDLQLQJLQWHQVLW\DQGH[WHQVLRQZDVREWDLQHGIRU(&DGKHULQ
(A)DQGF0HW(B)IURPHDFKVDPSOH
30DQQ:KLWQH\WHVWIRU(FDGKHULQDQGF0HWH[SUHVVLRQLQ$&DQGOLS6&&DVFRPSDUHG
WR1/3IRU(FDGKHULQDQGF0HWH[SUHVVLRQLQ$&DVFRPSDUHGWROLS6&&
Table 1.&HOOXODUORFDOL]DWLRQRI(FDGKHULQH[SUHVVLRQLQQRUPDOOLSDFWLQLFFKHLOLWLVDQGOLS6&&
E-cadherin Normal Lip Actinic Cheilitis Lip SCC 
    n    %     n   %   n   % 
Strong 18 100 12 33.3 
Membranous 
Mild   21 58.4 8 36.7 
Membranous 
Membranous    3 8.3 6 27.3
/Cytoplasmatic
Cytoplasmatic     1 4.2
Loss     7 31.8 
Total 18 100 36 100 22
Table 2. &HOOXODUORFDOL]DWLRQRIF0HWH[SUHVVLRQLQQRUPDOOLSDFWLQLFFKHLOLWLVDQGOLS6&&
C-Met Normal Lip Actinic Cheilitis Lip SCC 
    n    %    n   %    n    % 
No 11 61.1 
expression 
Mild 7 38.9
Membranous 
Membranous    2 5.5
/Cytoplasmatic
Cytoplasmatic   34 94 22 100
Total 18 100 36 100 22
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DISCUSSION
 E-cadherin and its associated intracellular catenins are a key 
cell-cell adhesion protein in epithelial cells(3). The loss of E-cadherin 
expression and/or function reduces cell-cell contacts and has been 
correlated with enhanced tumor progression and invasion(12,16). E-cadherin 
inactivation may also occur early in some premalignant lesions, and 
the loss of expression is thought to induce intracellular signaling that 
promotes tumor development and progression(5,10,13).
 The present study showed that the progression of actinic 
cheilitis, a premalignant lesion caused by chronic exposure to UV 
radiation, to lip SCC is closely associated with a significant reduction 
or loss of E-cadherin expression. The expression of E-cadherin was 
significantly decreased in lip SCC as compared to AC and normal lip. 
The data also showed that E-cadherin was significantly decreased in AC 
compared with normal lip. This is in agreement with other studies that 
found elevated expression of E-cadherin in normal oral epithelium(4,11), but 
weaker staining for E-cadherin in the dysplastic areas(5,6,9,11) as well as the 
infiltrating neoplastic islands of the invasive SCC carcinoma(5-7,9,11,12).
 Previously, we reported a significant increase in MDM-2 
epithelial expression in AC compared to normal lip(26). The use of 
immunohistochemical methods in breast cancer has led to lower levels of 
E-cadherin associated with higher expression of MDM-2(27). Yang et al.(27) 
identified E-cadherin as a new substrate for MDM-2, demonstrating that 
MDM2 ubiquitinates E-cadherin and decreases its protein levels.
 On the other hand, reduction or loss of E-cadherin expression 
together with increased COX-2 expression has been reported previously 
in HCA-7 colon carcinoma cells(28), in non-small cell lung cancer(16), and in 
prostate cancer(17).
 It has been demonstrated that COX-2 overexpression is 
a crucial event in the initial stage of UV-induced skin cancer(29). Our 
previous study found that in early lip carcinogenesis, COX-2 protein and 
mRNA expression increased in AC(30). Brouxhon et al.(6) using chronically 
UV-irradiated SKH-1 mice, showed a sequential loss of E-cadherin from 
dysplasia to SCCs; those authors also demonstrated that E-cadherin 
levels declined at the same time PG2 synthesis was enhanced.
 In several neoplasias, c-Met expression has been elevated 
in the tumor as well as in endothelial and inflammatory cells(7,15,19,20,22,23). 
These findings are corroborated in this study because the expression 
of c-Met increased significantly as lip carcinogenesis progressed. The 
result showed that in the early and later stages of lip carcinogenesis, 
c-Met expression was significantly increased in lip SCC as compared with 
the epithelium of AC lesions and normal lip. In addition, increased c-Met 
expression was found in stromal cells of lip SCC.
 Other studies from this group have shown that p53 epithelial 
expression is significantly increased in actinic cheilitis as compared 
to normal lip(26,31). Induction of p53 by UV irradiation in RKO cells that 
express wild-type p53 increases the level of endogenous c-Met gene 
product. Seol et al.(32) demonstrated that c-Met is induced by UV light and 
that p53 plays a role in this activation process.
 Conversely, HGF is well-known to be secreted by fibroblasts 
surrounding the tumor, helping cancer cells invade the all-around 
stroma(23,34). Chen et al.(23) observed that in oral SCC, parenchymal cells 
expressed high amounts of HGF and c-Met, as did stromal fibroblasts, 
endothelial cells, and inflammatory cells. Therefore, cancer cells are 
being stimulated to proliferate by autocrine and paracrine mechanisms. 
In the present study, we found that c-Met was expressed by stromal cells, 
some fibroblasts, endothelial cells, and inflammatory cells in AC (2.3%) 
samples and in lip SCC (50.3%).
 It has been shown that HGF regulates the expression of COX-2 
and increases synthesis of prostaglandins (PG) in gastric mucosal cells. 
Overexpression of COX-2 and increased PG secretion are involved in 
the regulation and growth of gastric cancer. Chen et al.(21) found 30 cases 
of gastric cancer overexpression of c-Met (93.3%) and COX-2 (53.3%). 
7KHH[SUHVVLRQRIF0HWZDVSRVLWLYHO\FRUUHODWHGZLWK&2;U 
3  6FDUSLQR HW DO(24) suggest that the increased expression of 
c-Met protein in thyroid papillary carcinoma played a role in up-regulating 
the expression of COX-2, which, in turn, contributes to the invasive 
capacity.
 Taken together, the reduction or loss of E-cadherin expression 
with increased c-Met expression in AC and lip SCC shown in our data 
agree with other studies that have demonstrated that the activation of 
c-Met by HGF is associated with decreased E-cadherin(7,13,18,33,34). Murai 
et al.(7) found a significant increase of c-Met expression in oral SCC as 
well as in dysplastic epithelium adjacent to tumor, and they suggest 
that the overexpression of c-Met interacts with E-cadherin to facilitate 
the disruption of intercellular junctions, thereby promoting invasion and 
metastasis. Shimabukuro et al.(34) reported that HGF produced by stromal 
cells influences the mode of stromal invasion of uterine squamous cervical 
cancer by decreasing E-cadherin.
 In summary, the results showed that epithelial E-cadherin 
expression is reduced and c-Met expression is increased as lip 
FDUFLQRJHQHVLV SURJUHVVHV QRUPDO OLS!$&!OLS 6&& VXJJHVWLQJ WKDW
these could be useful markers of malignant transformations in the lip. 
Future research should be performed to demonstrate the correlation of 
COX-2, c-Met, and E-cadherin in photodamaged lip.
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